197 related articles for article (PubMed ID: 26842712)
1. Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migration.
Takagi K; Miki Y; Tanaka S; Hashimoto C; Watanabe M; Sasano H; Ito K; Suzuki T
Endocr J; 2016; 63(3):287-99. PubMed ID: 26842712
[TBL] [Abstract][Full Text] [Related]
2. Nucleobindin 2 in human breast carcinoma as a potent prognostic factor.
Suzuki S; Takagi K; Miki Y; Onodera Y; Akahira J; Ebata A; Ishida T; Watanabe M; Sasano H; Suzuki T
Cancer Sci; 2012 Jan; 103(1):136-43. PubMed ID: 21988594
[TBL] [Abstract][Full Text] [Related]
3. High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patients.
Fu H; Zhu Y; Wang Y; Liu Z; Zhang J; Wang Z; Xie H; Dai B; Xu J; Ye D
Oncotarget; 2017 May; 8(21):35244-35254. PubMed ID: 27806328
[TBL] [Abstract][Full Text] [Related]
4. Nucleobindin-2/nesfatin-1 enhances the cell proliferation, migration, invasion and epithelial-mesenchymal transition in gastric carcinoma.
Ren L; Bao D; Wang L; Xu Q; Xu Y; Shi Z
J Cell Mol Med; 2022 Oct; 26(19):4986-4994. PubMed ID: 36065769
[TBL] [Abstract][Full Text] [Related]
5. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
Qi C; Ma H; Zhang HT; Gao JD; Xu Y
Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
[TBL] [Abstract][Full Text] [Related]
6. Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer.
Liu GM; Xu ZQ; Ma HS
Dis Markers; 2018; 2018():4272064. PubMed ID: 30327690
[TBL] [Abstract][Full Text] [Related]
7. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS.
Foo KS; Brismar H; Broberger C
Neuroscience; 2008 Oct; 156(3):563-79. PubMed ID: 18761059
[TBL] [Abstract][Full Text] [Related]
8. Ontogenic pattern of nucleobindin-2/nesfatin-1 expression in the gastroenteropancreatic tissues and serum of Sprague Dawley rats.
Mohan H; Unniappan S
Regul Pept; 2012 Apr; 175(1-3):61-9. PubMed ID: 22387700
[TBL] [Abstract][Full Text] [Related]
9. Nutrients differentially regulate nucleobindin-2/nesfatin-1 in vitro in cultured stomach ghrelinoma (MGN3-1) cells and in vivo in male mice.
Mohan H; Ramesh N; Mortazavi S; Le A; Iwakura H; Unniappan S
PLoS One; 2014; 9(12):e115102. PubMed ID: 25506938
[TBL] [Abstract][Full Text] [Related]
10. Nutrient status modulates the expression of nesfatin-1 encoding nucleobindin 2A and 2B mRNAs in zebrafish gut, liver and brain.
Hatef A; Shajan S; Unniappan S
Gen Comp Endocrinol; 2015 May; 215():51-60. PubMed ID: 25260251
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of overexpression of p53 in uterine endometrioid adenocarcinomas with an analysis of nuclear grade.
Urabe R; Hachisuga T; Kurita T; Kagami S; Kawagoe T; Matsuura Y; Shimajiri S
J Obstet Gynaecol Res; 2014 Mar; 40(3):812-9. PubMed ID: 24246002
[TBL] [Abstract][Full Text] [Related]
12. Paraventricular NUCB2/nesfatin-1 rises in synchrony with feeding suppression during early light phase in rats.
Sedbazar U; Maejima Y; Nakata M; Mori M; Yada T
Biochem Biophys Res Commun; 2013 May; 434(3):434-8. PubMed ID: 23583201
[TBL] [Abstract][Full Text] [Related]
13. Glucose, amino acids and fatty acids directly regulate ghrelin and NUCB2/nesfatin-1 in the intestine and hepatopancreas of goldfish (Carassius auratus) in vitro.
Bertucci JI; Blanco AM; Canosa LF; Unniappan S
Comp Biochem Physiol A Mol Integr Physiol; 2017 Apr; 206():24-35. PubMed ID: 28089858
[TBL] [Abstract][Full Text] [Related]
14. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
Li SS; Xue WC; Khoo US; Ngan HY; Chan KY; Tam IY; Chiu PM; Ip PP; Tam KF; Cheung AN
Histopathology; 2005 Mar; 46(3):307-13. PubMed ID: 15720416
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3sigma in endometrial cancer--a possible prognostic marker in early-stage cancer.
Ito K; Suzuki T; Akahira J; Sakuma M; Saitou S; Okamoto S; Niikura H; Okamura K; Yaegashi N; Sasano H; Inoue S
Clin Cancer Res; 2005 Oct; 11(20):7384-91. PubMed ID: 16243811
[TBL] [Abstract][Full Text] [Related]
16. The expression of S100P increases and promotes cellular proliferation by increasing nuclear translocation of β-catenin in endometrial cancer.
Guo L; Chen S; Jiang H; Huang J; Jin W; Yao S
Int J Clin Exp Pathol; 2014; 7(5):2102-12. PubMed ID: 24966918
[TBL] [Abstract][Full Text] [Related]
17. Nesfatin-1 inhibits ovarian epithelial carcinoma cell proliferation in vitro.
Xu Y; Pang X; Dong M; Wen F; Zhang Y
Biochem Biophys Res Commun; 2013 Nov; 440(4):467-72. PubMed ID: 23764403
[TBL] [Abstract][Full Text] [Related]
18. Paraventricular NUCB2/nesfatin-1 is directly targeted by leptin and mediates its anorexigenic effect.
Darambazar G; Nakata M; Okada T; Wang L; Li E; Shinozaki A; Motoshima M; Mori M; Yada T
Biochem Biophys Res Commun; 2015 Jan; 456(4):913-8. PubMed ID: 25534851
[TBL] [Abstract][Full Text] [Related]
19. Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status.
Koshiyama M; Yoshida M; Konishi M; Takemura M; Yura Y; Matsushita K; Hayashi M; Tauchi K
Int J Cancer; 1997 Jun; 74(3):237-44. PubMed ID: 9221798
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
